Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
154.57
+5.74 (3.86%)
At close: May 12, 2025, 4:00 PM
154.57
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 174.25, with a low estimate of 137 and a high estimate of 230. The average target predicts an increase of 12.73% from the current stock price of 154.57.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 9 | 10 | 10 | 11 | 9 | 9 |
| Hold | 3 | 3 | 3 | 3 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 18 | 18 | 19 | 18 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $175 → $190 | Strong Buy | Maintains | $175 → $190 | +22.92% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $134 → $154 | Hold | Maintains | $134 → $154 | -0.37% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $165 → $175 | Buy | Maintains | $165 → $175 | +13.22% | May 5, 2025 |
| Barclays | Barclays | Buy Maintains $161 → $171 | Buy | Maintains | $161 → $171 | +10.63% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $183 → $189 | Buy | Maintains | $183 → $189 | +22.27% | Apr 30, 2025 |
Financial Forecast
Revenue This Year
21.11B
from 20.67B
Increased by 2.16%
Revenue Next Year
22.16B
from 21.11B
Increased by 4.95%
EPS This Year
12.28
from 32.70
Decreased by -62.45%
EPS Next Year
13.34
from 12.28
Increased by 8.66%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.3B | 23.5B | 24.8B | ||
| Avg | 21.1B | 22.2B | 23.3B | ||
| Low | 20.3B | 21.1B | 21.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.8% | 11.4% | 11.8% | ||
| Avg | 2.2% | 4.9% | 5.0% | ||
| Low | -1.9% | -0.2% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.34 | 15.26 | 17.76 | ||
| Avg | 12.28 | 13.34 | 15.20 | ||
| Low | 11.34 | 11.23 | 12.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -59.2% | 24.3% | 33.1% | ||
| Avg | -62.4% | 8.7% | 13.9% | ||
| Low | -65.3% | -8.5% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.